[EN] β-1,6-GLUCAN THERAPEUTIC ANTIBODY CONJUGATES<br/>[FR] CONJUGUÉS D'ANTICORPS THÉRAPEUTIQUE DE β-1,6-GLUCANE
申请人:INNATE BIOTHERAPEUTICS LLC
公开号:WO2018106645A1
公开(公告)日:2018-06-14
The present invention encompasses embodiments in which a therapeutic antibody is conjugated to β-1,6-glucan oligomers. Thus, the present invention includes, among other things, compositions including a therapeutic antibody conjugated to one or more β-1-,6-glucan oligomers. The present invention further includes, among other things, methods of making and/or using such β-1,6-glucan conjugates. In certain embodiments, a β-1,6-glucan conjugate of the present invention is useful as a therapeutic or in a method of therapy.
本发明涵盖了将治疗性抗体与β-1,6-葡聚糖寡聚体结合的实施方式。因此,本发明包括包含治疗性抗体与一个或多个β-1,6-葡聚糖寡聚体结合的组合物,以及制备和/或使用这种β-1,6-葡聚糖结合物的方法。在某些实施方式中,本发明的β-1,6-葡聚糖结合物可用作治疗性药物或治疗方法。